Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
HPV
BD, MD Anderson launch pilot program for cervical cancer screening access
By
LabPulse.com staff writers
The study will evaluate the effectiveness of self-collected HPV testing in a real-world setting while aiming to identify challenges and solutions for cervical cancer screening in communities with limited healthcare access.
November 22, 2024
University of Florida researchers develop CRISPR-based assay for HPV detection
By
LabPulse.com staff writers
Researchers at the University of Florida have developed a testing method that utilizes CRISPR gene-editing technology to detect HPV in blood or saliva samples that could promote earlier cervical cancer detection.
May 7, 2024
HPV point-of-care test in development combines isothermal amplification, lateral flow detection
By
LabPulse.com staff writers
A testing platform that combines the two technologies often used separately in diagnostic tests could simplify the equipment and procedures needed for HPV testing.
June 23, 2023
Roche receives WHO prequalification for HPV screening tool
By
LabPulse.com staff writers
Prequalification helps expand access to the screening tool in countries that rely on the WHO's list of prequalified suppliers in making purchasing and implementation decisions.
June 13, 2023
Mailed HPV home test kits doubled cervical cancer screening rates in study
By
Elissa Wolfson
Mailing human papillomavirus (HPV) self-collection kits for at-home use improved cervical cancer screening in under-screened, low-income women by nearly two-fold.
May 12, 2023
Mayo Clinic, Naveris collaborate to evaluate HPV DNA test in clinical trial
By
LabPulse.com staff writers
The test is being developed with the aim of aiding treatment selection for patients with HPV-driven head and neck cancer.
April 13, 2023
Becton Dickinson HPV assay FDA approved with BD SurePath, Hologic ThinPrep Pap tests
By
LabPulse.com staff writers
The BD Onclarity HPV Assay individually tests for an extended set of HPV types, including HPV 31, which poses a higher risk for causing cervical precancer than HPV 18, Becton Dickinson said.
February 21, 2023
BioReference offering Roche Diagnostics cytology test for women at high risk for HPV
By
LabPulse.com staff writers
The test uses dual biomarker technology to simultaneously detect p16 and Ki-67 in women with HPV-positive results.
February 9, 2023
Virax Biolabs obtains CE Mark, introduces human papillomavirus test kit
By
LabPulse.com staff writers
The HPV test kit covers 18 genotypes of the human papillomavirus, including type 53, which is higher risk and becoming increasingly prevalent.
January 4, 2023
Enzo launches RNA gene expression platform for HPV
By
LabPulse.com staff writers
The platform's products combine sequence-specific probes with Enzo's LoopRNA in situ hybridization (ISH) technology, enabling the products to detect target genes in tissue or cell samples while preserving the morphology, Enzo said. This study of single cells within their native tissue environment, called spatial biology, helps scientists characterize and understand disease, Enzo added.
September 25, 2022
TTS, OmniPathology to offer oral HPV testing in L.A.
By
LabPulse.com staff writers
A throat swab enables the detection of 14 high-risk strains of HPV by pathologists at OmniPathology's high-complexity, CLIA-certified pathology laboratory in Pasadena, CA.
August 16, 2022
OmniPathology launches lab-developed test for HPV
By
LabPulse.com staff writers
The PCR-based test detects 14 high-risk strains of HPV, a virus with potential to progress to cancer. It is performed on a throat swab submitted for testing to OmniPathology's CLIA-certified laboratory in Pasadena, CA, and helps screen for oropharyngeal cancer and early premalignant lesions.
July 11, 2022
Page 1 of 4
Next Page